Wow, that’s quite an important presentation he’s giving to a very valuable company. I’d thought that Samsung Biologics might be related to Samsung proper, but never really looked into it. Let’s hope that Damsung is impressed with the presentation and offers an investment that can help CYDY stop dilutive financing, pay off not holders, get us to Combo revenue, and push these cancer indications through clinical trials.